Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$551M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$397M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$389M |
| 4 |
AABA
Altaba Inc
AABA
|
+$359M |
| 5 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$333M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$516M |
| 2 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$352M |
| 3 |
Lowe's Companies
LOW
|
+$252M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$219M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$167M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.34% |
| 2 | Financials | 4.89% |
| 3 | Consumer Discretionary | 3.06% |
| 4 | Healthcare | 3% |
| 5 | Industrials | 2.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Portland General Electric
POR
$5.71B
| $1.92M | ﹤0.01% |
47,431
+14,932
| +46% | +$613K |
|
2602
Madrigal Pharmaceuticals
MDGL
$11.8B
| $1.92M | ﹤0.01% |
16,438
+14,802
| +905% | +$1.83M |
|
|
KYNB
2603
Kyntra Bio
KYNB
$28.3M
| $1.92M | ﹤0.01% |
1,661
-2,277
| -58% | -$3M |
|
2604
CALL
Ligand Pharmaceuticals
LGND
$6.02B
| $1.92M | ﹤0.01% |
18,595
+13,946
| +300% | +$1.38M |
|
2605
Bio-Rad Laboratories Class A
BIO
$9.16B
| $1.92M | ﹤0.01% |
7,662
-35,423
| -82% | -$9.02M |
|
|
BRS
2606
DELISTED
Bristow Group, Inc.
BRS
| $1.91M | ﹤0.01% |
146,766
+146,354
| +35,523% | +$2.18M |
|
|
AXON
2607
CALL
Axon Enterprise
AXON
$42.1B
| $1.91M | ﹤0.01% |
48,500
+18,900
| +64% | +$589K |
|
2608
iShares MSCI Peru and Global Exposure ETF
EPU
$559M
| $1.91M | ﹤0.01% |
44,740
-5,770
| -11% | -$244K |
|
2609
CALL
Cameco
CCJ
$40.8B
| $1.9M | ﹤0.01% |
209,300
-284,900
| -58% | -$2.64M |
|
2610
PUT
Ashland
ASH
$3.32B
| $1.9M | ﹤0.01% |
27,200
+11,000
| +68% | +$792K |
|
|
NATI
2611
DELISTED
National Instruments Corp
NATI
| $1.89M | ﹤0.01% |
37,379
+26,922
| +257% | +$1.31M |
|
2612
PUT
Conagra Brands
CAG
$7.11B
| $1.89M | ﹤0.01% |
51,200
-54,200
| -51% | -$2M |
|
|
FIVA
2613
Fidelity International Value Factor ETF
FIVA
$597M
| $1.89M | ﹤0.01% |
+80,000
| New | +$1.92M |
|
2614
WisdomTree
WT
$3.26B
| $1.89M | ﹤0.01% |
205,732
+57,488
| +39% | +$621K |
|
2615
PUT
Equinix
EQIX
$104B
| $1.88M | ﹤0.01% |
4,500
-5,100
| -53% | -$2.15M |
|
|
CLVS
2616
PUT
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.88M | ﹤0.01% |
35,600
-22,700
| -39% | -$1.32M |
|
2617
CALL
Polaris
PII
$3.99B
| $1.88M | ﹤0.01% |
16,400
-18,100
| -52% | -$2.18M |
|
2618
PUT
Vipshop
VIPS
$7.4B
| $1.88M | ﹤0.01% |
113,000
-400
| -0.4% | -$6.61K |
|
|
CHL
2619
PUT
DELISTED
China Mobile Limited
CHL
| $1.88M | ﹤0.01% |
40,900
-44,300
| -52% | -$2.15M |
|
2620
PUT
Snap-on
SNA
$21.5B
| $1.87M | ﹤0.01% |
12,700
+9,100
| +253% | +$1.5M |
|
|
NFX
2621
CALL
DELISTED
Newfield Exploration
NFX
| $1.87M | ﹤0.01% |
76,700
+38,100
| +99% | +$1.07M |
|
2622
CALL
Nasdaq
NDAQ
$52.9B
| $1.87M | ﹤0.01% |
65,100
-36,000
| -36% | -$972K |
|
2623
XPO
XPO
$23B
| $1.87M | ﹤0.01% |
53,141
+29,648
| +126% | +$989K |
|
|
CIM
2624
Chimera Investment
CIM
$992M
| $1.87M | ﹤0.01% |
35,778
-22,106
| -38% | -$1.16M |
|
2625
CALL
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$570M
| $1.87M | ﹤0.01% |
1,175
+835
| +246% | +$1.55M |
|
Similar funds
Citigroup's Q1 2018 Portfolio in Review
As of Q1 2018, Citigroup held 7,881 positions worth $121B, down 2.7% from $125B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Citigroup's Q1 2018 filing shows 268 new, 3,114 increased, 3,575 reduced and 287 closed positions. Its largest new stake was Nutrien: 402,771 shares worth $19M. The largest sale was iShares MSCI USA Min Vol Factor ETF, an estimated $516M.
By sector, the portfolio is most concentrated in Technology at 5.3% of assets, up from 4.2% a quarter earlier, followed by Financials and Consumer Discretionary.
- Citigroup's largest Q1 2018 buy was Nutrien: 402,771 shares worth $19M.
- Citigroup added most to Invesco QQQ Trust in Q1 2018, an estimated $551M increase.
- Citigroup's biggest Q1 2018 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $516M.
- Citigroup fully exited Scripps Networks Interactive, Inc Common Class A in Q1 2018, selling an estimated $82.7M.
- Citigroup's ten largest holdings make up 28% of its $121B portfolio in Q1 2018.
- Citigroup opened 268 new positions and closed 287 in Q1 2018.
- Citigroup's portfolio value fell 2.7% quarter-over-quarter to $121B.
Based on Citigroup's 13F filing for Q1 2018, filed 11 May 2018.